• Foundation Honors 4 Individuals for their Contributions to Angelman Research, Patient Advocacy
  • Building an Individualized Education Plan for a Child With Angelman Syndrome
  • Potential Angelman’s Treatment, GTX-102, Named Orphan Drug and Rare Pediatric Disease Therapy by FDA
  • Speech and Language Delays in Angelman Syndrome and How to Deal With Them
  • ‘Disorder’ Film Festival Offers Look at Siblings Touched by Rare Diseases
  • How to Build a Treatment Plan for School/Daycare for a Child with Angelman Syndrome
  • At NY Genome Center, Legal Expert Presents Ethical Dilemmas in Gene Editing
  • Blocking Two Proteins Linked to UBE3A Activity Might Treat Angelman, Study Suggests
  • 5 Tips for Making Every Doctor’s Visit Count When Your Child Has Angelman Syndrome
  • Rare Resilience: Is There a Gene for That?
  • Neuren’s Investigational NNZ-2591 Rescues Motor and Cognitive Functions, Mouse Study Shows
  • Nebraska’s Neena Nizar Seeks Cure for Jansen’s, One of World’s Rarest Diseases